British competition regulator objects to Google’s ad tech practices

British competition regulator objects to Google’s ad tech practices


The entrance to Google’s U.K. offices in London.

Olly Curtis | Future Publishing | via Getty Images

LONDON — Britain’s competition watchdog on Friday issued a statement of objections over Google’s ad tech practices, which the regulator provisionally found are impacting competition in the U.K.

In a statement, the Competition and Markets Authority alleged that the U.S. internet search titan “has harmed competition by using its dominance in online display advertising to favour its own ad tech services.”

The “vast majority” of the U.K.’s thousands of publishers and advertisers use Google’s technology in order to bid for and sell space to display ads, the CMA said.

The regulator added that it is also “concerned that Google is actively using its dominance in this sector to preference its own services.” So-called “self-preferencing” of services by technology giants is a key concern for regulators scrutinizing these companies.

The CMA further noted that Google disadvantages ad technology competitors, preventing them from competing on a “level playing field.”

Google did not immediately respond to a CNBC request for comment.

This is a breaking news story. Please check back for further updates.



Source

Stock futures are little changed as Wall Street eyes latest developments in Middle East and oil prices: Live updates
World

Stock futures are little changed as Wall Street eyes latest developments in Middle East and oil prices: Live updates

A trading floor manager works on the floor of the American Stock Exchange (AMEX) at the New York Stock Exchange (NYSE) in New York, US, on Monday, May 4, 2026. Michael Nagle | Bloomberg | Getty Images U.S. stock futures were little changed on Monday night after the major averages suffered declines amid growing concerns […]

Read More
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance
World

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance

Still life of the new Wegovy semaglutide tablets on a white background. Its a prescription medicine used with a reduced calorie diet and .and physical activity. Michael Siluk | Universal Images Group | Getty Images When the Wegovy pill launched in January, telehealth provider LifeMD said its business doubled almost overnight.  LifeMD went from seeing […]

Read More
Circle jumps 16% on Clarity Act compromise that preserves stablecoin rewards
World

Circle jumps 16% on Clarity Act compromise that preserves stablecoin rewards

Circle Internet Group Initial Public Offering at the New York Stock Exchange in New York City, U.S., June 5, 2025. NYSE Shares of Circle surged after lawmakers over the weekend struck a compromise on the market structure bill known as the CLARITY Act, preserving stablecoin reward programs under certain conditions. On Friday, key language in […]

Read More